The GSK oncology products it has sold on to Novartis were ... particularly if GSK is not looking to reinvest in oncology. However a major outlay looks unlikely, at least in connection to the ...

Three years after the discovery of the human immunodeficiency virus (HIV) in 1984, GlaxoSmithKline's (GSK ... it was found that major and prolonged reductions in viral burden could be achieved ...

GSK is one of the pharma industry's top vaccine producers, giving Affinivax' shot the marketing muscle it will need to challenge Pfizer's Prevnar 13 and Prevnar 20 products – targeting 13 and 20 ...